|
Market Closed -
OTC Markets
20:00:15 14/05/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | +9,900.00% |
|
-.--% | +9,900.00% |
| 11/12/18 | Alternate Health Announces Executive Changes | CI |
| 02/02/18 | Alternate Health Corp Announces Executive Changes | CI |
| Market Cap | 5.7M 4.91M 4.6M 4.2M 7.92M 544M 7.94M 54.61M 21.31M 275M 21.39M 20.92M 911M | P/E 2017 |
-3.04x | P/E 2018 | -0.76x |
|---|---|---|---|---|---|
| Enterprise Value | 4.92M 4.24M 3.98M 3.63M 6.84M 471M 6.86M 47.2M 18.42M 238M 18.49M 18.09M 788M | EV / Sales 2017 |
6.25x | EV / Sales 2018 | 37.9x |
| Free-Float |
100% | Yield 2017 * |
-
| Yield 2018 | - |
| 1 day | +9,900.00% | ||
| 6 months | +9,900.00% | ||
| Current year | +9,900.00% |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0 | |
| 5 years | 0 | 0.75 | |
| 10 years | 0 | 6.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Howard Mann
CEO | Chief Executive Officer | - | 11/12/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
James E. Tykoliz
BRD | Director/Board Member | - | 16/04/2015 |
| Chairman | - | 05/04/2017 | |
Howard Mann
BRD | Director/Board Member | - | 11/12/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/06/20 | Sell | Chairman | 8,727,896 | 11.2061% | ||
| 12/06/20 | Other | Chairman | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +9,900.00% | -.--% | +9,900.00% | -.--% | 9.15K | ||
| +0.02% | +1.36% | -12.54% | -5.59% | 13.26B | ||
| +0.53% | +2.99% | -32.15% | -56.36% | 4.99B | ||
| +0.27% | +1.59% | -3.46% | +0.53% | 4.66B | ||
| -0.43% | -1.64% | -0.25% | -29.65% | 4.02B | ||
| +0.08% | +3.06% | -17.20% | +7.02% | 3.59B | ||
| -0.67% | +2.71% | -2.91% | -3.69% | 3.43B | ||
| +0.47% | -0.53% | -10.57% | +8.77% | 3.31B | ||
| -2.19% | -2.26% | -24.23% | -12.67% | 2.38B | ||
| +0.74% | +2.97% | -26.68% | -9.75% | 1.72B | ||
| Average | +989.88% | +1.71% | +977.00% | -10.14% | 4.14B | |
| Weighted average by Cap. | -0.04% | +1.73% | -13.40% | -11.54% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 13.25M 11.42M 10.71M 9.78M 18.42M 1.27B 18.47M 127M 49.57M 639M 49.77M 48.68M 2.12B | 577K 497K 466K 426K 802K 55.16M 804K 5.53M 2.16M 27.85M 2.17M 2.12M 92.33M |
| Net income | -26.13M -22.52M -21.12M -19.27M -36.31M -2.5B -36.43M -251M -97.74M -1.26B -98.12M -95.99M -4.18B | -23.99M -20.67M -19.38M -17.69M -33.33M -2.29B -33.43M -230M -89.71M -1.16B -90.06M -88.1M -3.84B |
| Net Debt | -893K -769K -721K -658K -1.24M -85.3M -1.24M -8.56M -3.34M -43.06M -3.35M -3.28M -143M | -773K -666K -624K -570K -1.07M -73.84M -1.08M -7.41M -2.89M -37.27M -2.9M -2.84M -124M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- AHGIF Stock
Select your edition
All financial news and data tailored to specific country editions
















